LH receptor gene expression is essentially absent in breast tumor tissue: Implications for treatment
- 1 April 2009
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 302 (1) , 58-64
- https://doi.org/10.1016/j.mce.2008.12.016
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- GnRH and LHRgene variants predict adverse outcome in premenopausal breast cancer patientsBreast Cancer Research, 2007
- Human chorionic gonadotropin (hCG) and prevention of breast cancerMolecular and Cellular Endocrinology, 2007
- Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivoMolecular and Cellular Endocrinology, 2006
- Epidemiology and the causes of breast cancerInternational Journal of Cancer, 2006
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious MutantsCancer Research, 2006
- How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective StudyClinical Cancer Research, 2005
- Coordinated Changes in DNA Methylation and Histone Modifications Regulate Silencing/Derepression of Luteinizing Hormone Receptor Gene TranscriptionMolecular and Cellular Biology, 2005
- Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomasCancer, 2003
- Risk factors and risk reduction of breast and ovarian cancerCurrent Opinion in Obstetrics and Gynecology, 2003